Vijay K. Kuchroo

Vijay K. Kuchroo

Top Cited Scholar 2026
Auto-generated profile, based on publicly available information

Vijay K. Kuchroo

Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Mass General Hospital and Harvard Medical School and Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2009 in Annual Review of Immunology
Verified
Journal Article
Closed access
TKThomas Korn
Thomas Korn
EBEstelle Bettelli
Estelle Bettelli
MOMohamed Oukka
Mohamed Oukka
VKVijay K. Kuchroo
Vijay K. Kuchroo
CD4+T cells, upon activation and expansion, develop into different T helper cell subsets with different cytokine profiles and distinct effector functions. Until recently, T cells were divided into Th1 or Th2 cells, depending on the cytokines they produce. A third subset of IL-17-producing effector T helper cells, called Th17 cells, has now been discovered and characterized. Here, we summarize the current information on the differentiation and effector functions of the Th17 lineage. Th17 cells produce IL-17, IL-17F, and IL-22, thereby inducing a massive tissue reaction owing to the broad distribution of the IL-17 and IL-22 receptors. Th17 cells also secrete IL-21 to communicate with the cells of the immune system. The differentiation factors (TGF-β plus IL-6 or IL-21), the growth and stabilization factor (IL-23), and the transcription factors (STAT3, RORγt, and RORα) involved in the development of Th17 cells have just been identified. The participation of TGF-β in the differentiation of Th17 cells places the Th17 lineage in close relationship with CD4+CD25+Foxp3+regulatory T cells (Tregs), as TGF-β also induces differentiation of naive T cells into Foxp3+Tregs in the peripheral immune compartment. The investigation of the differentiation, effector function, and regulation of Th17 cells has opened up a new framework for understanding T cell differentiation. Furthermore, we now appreciate the importance of Th17 cells in clearing pathogens during host defense reactions and in inducing tissue inflammation in autoimmune disease.

1 May 2016 in Immunity
Verified
Journal Article
Closed access
AAAna C. Anderson
Ana C. Anderson
NJNicole Joller
Nicole Joller
VKVijay K. Kuchroo
Vijay K. Kuchroo

6 September 2010 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
KSKaori Sakuishi
Kaori Sakuishi
LALionel Apetoh
Lionel Apetoh
JSJenna M. Sullivan
Jenna M. Sullivan
BBBruce R. Blazar
Bruce R. Blazar
VKVijay K. Kuchroo
Vijay K. Kuchroo
AAAna C. Anderson
Ana C. Anderson
The immune response plays an important role in staving off cancer; however, mechanisms of immunosuppression hinder productive anti-tumor immunity. T cell dysfunction or exhaustion in tumor-bearing hosts is one such mechanism. PD-1 has been identified as a marker of exhausted T cells in chronic disease states, and blockade of PD-1–PD-1L interactions has been shown to partially restore T cell function. We have found that T cell immunoglobulin mucin (Tim) 3 is expressed on CD8+ tumor-infiltrating lymphocytes (TILs) in mice bearing solid tumors. All Tim-3+ TILs coexpress PD-1, and Tim-3+PD-1+ TILs represent the predominant fraction of T cells infiltrating tumors. Tim-3+PD-1+ TILs exhibit the most severe exhausted phenotype as defined by failure to proliferate and produce IL-2, TNF, and IFN-γ. We further find that combined targeting of the Tim-3 and PD-1 pathways is more effective in controlling tumor growth than targeting either pathway alone.

20 June 2007 in Nature
Verified
Journal Article
Closed access
PDF file
TKThomas Korn
Thomas Korn
EBEstelle Bettelli
Estelle Bettelli
WGWenda Gao
Wenda Gao
AAAmit Awasthi
Amit Awasthi
AJAnneli Jäger
Anneli Jäger
VKVijay K. Kuchroo
Vijay K. Kuchroo

9 September 2012 in Nature Immunology
Verified
Journal Article
Open access
PDF file
YLYoujin Lee
Youjin Lee
AAAmit Awasthi
Amit Awasthi
NYNir Yosef
Nir Yosef
FQFrancisco J Quintana
Francisco J Quintana
SXSheng Xiao
Sheng Xiao
VKVijay K Kuchroo
Vijay K Kuchroo
Exposure to interleukin 23 (IL-23) is required for the induction of pathogenic TH17 cells. Kuchroo and colleagues show that IL-23-dependent induction of the cytokine TGF-β3 produces a molecular signature characteristic of highly pathogenic TH17 cells. Interleukin 17 (IL-17)-producing helper T cells (TH17 cells) are often present at the sites of tissue inflammation in autoimmune diseases, which has led to the conclusion that TH17 cells are main drivers of autoimmune tissue injury. However, not all TH17 cells are pathogenic; in fact, TH17 cells generated with transforming growth factor-β1 (TGF-β1) and IL-6 produce IL-17 but do not readily induce autoimmune disease without further exposure to IL-23. Here we found that the production of TGF-β3 by developing TH17 cells was dependent on IL-23, which together with IL-6 induced very pathogenic TH17 cells. Moreover, TGF-β3-induced TH17 cells were functionally and molecularly distinct from TGF-β1-induced TH17 cells and had a molecular signature that defined pathogenic effector TH17 cells in autoimmune disease.

19 June 2008 in Nature
Verified
Journal Article
Closed access
PDF file
EBEstelle Bettelli
Estelle Bettelli
TKThomas Korn
Thomas Korn
MOMohamed Oukka
Mohamed Oukka
VKVijay K. Kuchroo
Vijay K. Kuchroo